Delivery Order SPE2DB20D2014-SPE2DB23FD38C
Award Date 9/18/23
Potential Completion Date 9/19/23
Potential Value $16K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $19,828 delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. The firm fixed price order is for 2ML pens to be delivered from Amerisourcebergen's Conshohocken, Pennsylvania facility to an unknown customer by July 28, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations, suggesting this order for the injectable drug DUPIXENT supports the healthcare needs of DOD personnel. No set...
- <p>The Defense Logistics Agency awarded a $33,988 delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. The firm fixed price order is being fulfilled from Amerisourcebergen's Conshohocken, Pennsylvania location to support the Department of Defense. No additional context was provided regarding the Defense Logistics Agency's programs or any subcontractors involved. The delivery order has performance periods from August 4th through August 7th, 2023.</p>
- The Defense Logistics Agency awarded a $15,288 delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Under this firm fixed price contract, Amerisourcebergen will deliver the pharmaceutical product to a location in Conshohocken, Pennsylvania by August 28, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations, suggesting this delivery order supports DOD medical supply needs. No additional details were provided regarding...
- The Defense Logistics Agency awarded a $3,776.92 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. As the prime contractor, Amerisourcebergen will deliver the medication to a location in Conshohocken, Pennsylvania by August 30th, 2023 in support of DLA programs. No subcontractors or set aside designations were indicated. DLA facilitates procurement for the Department of Defense and this order for the injectable drug DUPIXENT aligns with the...
- The Defense Logistics Agency awarded a $9,019.66 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pen injectors. As the prime contractor, Amerisourcebergen will deliver the pen injectors to a location in Conshohocken, Pennsylvania by September 7, 2023 to fulfill requirements under the agency's pharmaceutical supply chain contracts. No set aside designation or subcontractors were indicated. The Defense Logistics Agency manages the Department of...
- The Defense Logistics Agency awarded a $24,087.66 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over one day in August 2023. The Defense Logistics Agency manages the global supply chain for the United States...
- The Defense Logistics Agency awarded a $14,649.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Under this contract, Amerisourcebergen will provide approximately 2,000 ML of the drug to support the Defense Logistics Agency's medical supply needs. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is July 21-24, 2023. No subcontractors or set aside designations were identified....
- The Defense Logistics Agency awarded a $25,844.06 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. The delivery order is associated with DLA's Prime Vendor Program and supports the agency's medical supply needs. Amerisourcebergen will deliver the DUPIXENT pens to a location in Conshohocken, Pennsylvania by August 11, 2023 to fulfill the Defense Logistics Agency's requirements. No subcontractors or set aside designations were identified in the...
- The Defense Logistics Agency awarded a $11,765.88 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. The order is for 2ML pens of DUPIXENT, which is used to treat atopic dermatitis and asthma. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania by August 31, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for the United...
- The Defense Logistics Agency awarded a $8,092 delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. The firm fixed price order is for a one day period of performance from July 11 to July 12, 2023. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania to support the Defense Logistics Agency's supply chain needs. No major subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB23FD38CDelivery Order
The Defense Logistics Agency awarded a $15,597 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. The order is for 2 ML of the drug and will be fulfilled by Amerisourcebergen from its facility in Conshohocken, Pennsylvania by September 19, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations, suggesting this order for the auto-injectable drug DUPIXENT supports DOD medical readiness and treatment programs. No major subcontractors or set aside designations were indicated.
Generated 12/18/23, 1:28 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.6k | 9/18/23 |